Home Tools
Log in
Cart

Search Result

Search Results for " gsk-3 inhibitor 3 "

20

Compounds

Cat No. Product Name Synonyms Targets
T77342 GSK-3 inhibitor 3 GSK-3 , Microtubule Associated
GSK-3 inhibitor 3 is a selective, orally active, brain-permeable GSK-3 inhibitor that inhibits GSK-3α and GSK-3β with IC50s of 0.35 nM and 0.25 nM, respectively.GSK-3 inhibitor 3 reduces the phosphorylation level of tau ...
T35554 GSK-3β inhibitor 3 Apoptosis , GSK-3
GSK-3β inhibitor 3 is a covalent inhibitor (IC50: 6.6 μM) of glycogen synthase kinase 3β (GSK-3β) that is potent, selective, and irreversible.GSK-3β inhibitor 3 can be used to study acute promyelocytic leukemia.
T11468 GSK-3 inhibitor 1 GSK-3
GSK-3 inhibitor 1 is a GSK-3 inhibitor.
T1917 GSK 3 Inhibitor IX BIO,GSK 3 IX,6-BIO,6-Bromoindirubin-3'-oxime,MLS 2052,6-bromoindirubin-3-oxime Apoptosis , GSK-3 , Tyrosine Kinases , CDK
GSK 3 Inhibitor IX (6-BIO) is a selective reversible, ATP-competitive inhibitor of GSK-3α/β and CDK1-cyclinB complex. It inhibits (GSK-3α/β)/CDK1/CDK5 activity with IC50 values of 5 nM/320 nM/83 nM, respectively.
T77554 GSK-3 Inhibitor 5 4-Cyanophenacyl bromide GSK-3
GSK-3 Inhibitor 5 (4-Cyanophenacyl bromide) is a ketone derivative that is used as an intermediate in pharmaceuticals and organic synthesis, and inhibits glycogen synthase kinase 3 (GSK-3).
T77341 GSK-3 inhibitor 4 GSK-3 , CDK
GSK-3 inhibitor 4 is an orally active and brain-permeable triple inhibitor of GSK-3, CDK2 and CDK5 with inhibitory effects on GSK-3β, GSK-3α, CDK2 and CDK5, with IC50 values of 0.56 nM, 0.45 nM, 0.47 μM, 0.68 μM, respect...
T11467 GSK-3β inhibitor 1 GSK-3
GSK-3β inhibitor 1 is an inhibitor of GSK-3β( IC50 of 4.9 nM) and demonstrates high antidiabetic efficacy.
T6787 BIO-acetoxime BIA,GSK-3 Inhibitor X Apoptosis , GSK-3 , HSV
BIO-acetoxime (GSK-3 Inhibitor X) is a potent dual GSK3α/β inhibitor with IC50 of 10 nM, >240-fold selectivity over CDK5/p25, CDK2/cyclin A and CDK1/cyclin B.
T9725 GSK-3β inhibitor 10 Others
GSK-3β inhibitor 10 has skin-whitening, anti-oxidizing and PPAR activities.
T78578 GSK-3 Inhibitor XIII GSK-3
GSK-3 Inhibitor XIII, an ATP-competitive GSK-3 inhibitor (Ki: 24 nM), can be used to study diabetes and obesity.
T9178 (E/Z)-GSK-3β inhibitor 1 GSK-3β inhibitor 1 GSK-3
(E/Z)-GSK-3β inhibitor 1 is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabetic efficacy.
T24111 GSK3i XIII GSK3 inhibitor XIII,GSK3iXIII,GSK3i-XIII GSK-3
GSK3i XIII (GSK3 inhibitor XIII) is a GSK-3 ATP-binding site inhibitor.
T2073 GSK2636771 GSK 2636771,GSK-2636771 PI3K
GSK2636771, an effective, specific, orally bioavailable, PI3inhibitor, has been used in cancer, lymphoma, solid neoplasm, recurrent solid neoplasm, and advanced malignant neoplasm.
T6187 TDZD-8 GSK-3β Inhibitor I,NP 01139 GSK-3
TDZD-8 (NP 01139) is an inhibitor of GSK-3β, with an IC50 of 2 μM; minimal inhibitory effect observed on CDK1, casein kinase II, PKA and PKC.
T1965 Bikinin Abrasin Others , GSK-3
Bikinin (Abrasin), a potent inhibitor of plant GSK-3/Shaggy-like kinase, activates BR signaling downstream of the BR receptor.
T1881 AR-A014418 AR 0133418,GSK-3beta Inhibitor VIII,AR 014418,GSK 3β inhibitor VIII GSK-3
AR-A014418 (GSK 3β inhibitor VIII) is an ATP-competitive, and selective GSK3β inhibitor.
T9987 GSK3-IN-1 GSK-3
GSK3-IN-1 is a GSK3B-glycogen synthase kinase-3 beta inhibitor.
T10202 A 1070722 GSK-3
A 1070722 is a potent and selective GSK-3 inhibitor, with a Ki of 0.6 nM for both GSK-3α and GSK-3β. It can penetrate the blood-brain barrier (BBB) and accumulates in brain regions, thus potential for PET radiotracer for...
T2357 GSK1059615 GSK 1059615,GSK-1059615 Apoptosis , PI3K , mTOR
GSK1059615 has been used in trials studying the treatment of Lymphoma, Solid Tumours, Endometrial Cancer, Solid Tumor Cancer, and Metastatic Breast Cancer.
T1741 AZD1080 GSK-3
AZD1080 is a selective, orally active, brain permeable GSK3 inhibitor.
1 2 3 4 5
TargetMol